AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 292 min read$CBRS

Patel Yagnesh sold $697K of CBRS

Patel Yagnesh (Chief Accounting Officer) sold 4,000 shares of Cerebras Systems Inc. (CBRS) at an average of $174.20 ($161.61–$189.36, $0.70M total) across 15 trades over 2026-06-25 to 2026-06-26.

Original reporting
SEC EDGAR · Patel Yagnesh
Published Jun 29, 2026, 8:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 29, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The newest fact is the CFO’s/CAO’s open-market sale totaling ~$696.8K at a range of prices, leaving the insider with 0 shares post-transaction.

02

Market read

Traders may monitor for follow-on insider activity, but there is no accompanying fundamental update in the filing text.

03

What to watch

The disclosure lacks context on taxes, diversification needs, or whether other insiders/large holders acted around the same time; without that, directional inference is weak.

Relevance 5/10Novelty 5/10Timing: filed after-hours on 2026-06-29 (SEC Form 4 disclosure)

Background

The article is an SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems CFO Patel Yagnesh sold ~$696.8K of CBRS shares (4,000 total) across 15 trades at $161.61–$189.36.

Expected impact

Likely limited/short-lived impact; any effect would be sentiment-driven rather than a re-rating catalyst.

Evidence & confidence

The filing is a Form 4 insider sale with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deal, or regulatory action).

Market effects

Sector

Minimal; this is company-specific insider activity with no sector-wide regulatory/product signal.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be routine liquidity/portfolio rebalancing (no 10b5-1 plan is stated, but insider sales are often non-informational).

Key entities

  • issuer
    Cerebras Systems Inc.

    Company whose insider transaction is disclosed on SEC Form 4 (CBRS).

  • insider
    Patel Yagnesh

    Chief Accounting Officer reporting the sale of CBRS shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CBRS insider trading history →

Related articles

OCT 6
$CBRSMed

Cerebras stock jumps 9%; Q3 sales guide sets a harder test

Cerebras Systems (CBRS) stock rose 9% after OpenAI's Sam Altman reaffirmed their partnership. The company's Q3 revenue guidance suggests 2.4% sequential growth. OpenAI committed to 750MW of capacity, with an option for 1.25GW. Cerebras reported $56.8M in OpenAI-related revenue in Q2, 31.5% of total GAAP revenue. The stock remains below its IPO price of $185.

techi.com2 min
OCT 5
$CBRSHigh

CBRS Stock Surges Over 6% in Monday Pre-Market: What's the Sam Altman Connection? - Cerebras Systems (NAS

Cerebras Systems (CBRS) shares rose 6.56% premarket after OpenAI CEO Sam Altman called it a 'close partner,' easing concerns. Analysts noted strong ties with OpenAI, despite Nvidia (NVDA) running its new model. Barclays' Tom O'Malley called the sell-off 'overdone,' while Paul Meeks upgraded CBRS to Buy with a $209 target, citing high AI demand. CBRS is down 52.45% YTD.

benzinga.com2 min
OCT 5
$CBRSMed

Mizuho reiterates Cerebras Systems stock rating on inference growth

Mizuho reiterated its Outperform rating and $300 price target for Cerebras Systems (CBRS), citing growth in fast inference workloads. The firm projects a $550B market by 2030, with CBRS trading near its 52-week low at $166.43. CBRS reported 91% revenue growth over the last year, and analysts have revised earnings upwards, though some suggest overvaluation. The company unveiled the CS-4 system, with improved performance and compute density, expected in Q3.

investing.com2 min